Insmed's Brinsupri wins Japan approval for bronchiectasis
Insmed says Japan's Ministry of Health, Labour and Welfare approved BRINSUPRI (brensocatib) for patients with non-cystic fibrosis bronchiectasis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.